Outcomes in patients tested for Clostridium difficile toxins

Christopher R Polage, David L. Chin, Jhansi L. Leslie, Jevon Tang, Stuart H Cohen, Jay V Solnick

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Clostridium difficile testing is shifting from toxin detection to C. difficile detection. Yet, up to 60% of patients with C. difficile by culture test negative for toxins and it is unclear whether they are infected or carriers. We reviewed medical records for 7046 inpatients with a C. difficile toxin test from 2005 to 2009 to determine the duration of diarrhea and rate of complications and mortality among toxin-positive (toxin+) and toxin- patients. Overall, toxin- patients had less severe diarrhea, fewer diarrhea days, and lower mortality (P < 0.001, all comparisons) than toxin+ patients. One toxin- patient (n = 1/6121; 0.02%) was diagnosed with pseudomembranous colitis, but there were no complications such as megacolon or colectomy for fulminant CDI among toxin- patients. These data suggest that C. difficile-attributable complications are rare among patients testing negative for C. difficile toxins. More studies are needed to evaluate the clinical significance of C. difficile detection in toxin- patients.

Original languageEnglish (US)
Pages (from-to)369-373
Number of pages5
JournalDiagnostic Microbiology and Infectious Disease
Volume74
Issue number4
DOIs
StatePublished - Dec 2012

Fingerprint

Clostridium difficile
Diarrhea
Megacolon
Pseudomembranous Enterocolitis
Mortality
Colectomy
Medical Records
Inpatients

Keywords

  • Clostridium difficile
  • Diarrhea
  • Healthcare-associated infection
  • Outcomes
  • Toxin

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Outcomes in patients tested for Clostridium difficile toxins. / Polage, Christopher R; Chin, David L.; Leslie, Jhansi L.; Tang, Jevon; Cohen, Stuart H; Solnick, Jay V.

In: Diagnostic Microbiology and Infectious Disease, Vol. 74, No. 4, 12.2012, p. 369-373.

Research output: Contribution to journalArticle

@article{dfb544623394426f9867354382ef331a,
title = "Outcomes in patients tested for Clostridium difficile toxins",
abstract = "Clostridium difficile testing is shifting from toxin detection to C. difficile detection. Yet, up to 60{\%} of patients with C. difficile by culture test negative for toxins and it is unclear whether they are infected or carriers. We reviewed medical records for 7046 inpatients with a C. difficile toxin test from 2005 to 2009 to determine the duration of diarrhea and rate of complications and mortality among toxin-positive (toxin+) and toxin- patients. Overall, toxin- patients had less severe diarrhea, fewer diarrhea days, and lower mortality (P < 0.001, all comparisons) than toxin+ patients. One toxin- patient (n = 1/6121; 0.02{\%}) was diagnosed with pseudomembranous colitis, but there were no complications such as megacolon or colectomy for fulminant CDI among toxin- patients. These data suggest that C. difficile-attributable complications are rare among patients testing negative for C. difficile toxins. More studies are needed to evaluate the clinical significance of C. difficile detection in toxin- patients.",
keywords = "Clostridium difficile, Diarrhea, Healthcare-associated infection, Outcomes, Toxin",
author = "Polage, {Christopher R} and Chin, {David L.} and Leslie, {Jhansi L.} and Jevon Tang and Cohen, {Stuart H} and Solnick, {Jay V}",
year = "2012",
month = "12",
doi = "10.1016/j.diagmicrobio.2012.08.019",
language = "English (US)",
volume = "74",
pages = "369--373",
journal = "Diagnostic Microbiology and Infectious Disease",
issn = "0732-8893",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Outcomes in patients tested for Clostridium difficile toxins

AU - Polage, Christopher R

AU - Chin, David L.

AU - Leslie, Jhansi L.

AU - Tang, Jevon

AU - Cohen, Stuart H

AU - Solnick, Jay V

PY - 2012/12

Y1 - 2012/12

N2 - Clostridium difficile testing is shifting from toxin detection to C. difficile detection. Yet, up to 60% of patients with C. difficile by culture test negative for toxins and it is unclear whether they are infected or carriers. We reviewed medical records for 7046 inpatients with a C. difficile toxin test from 2005 to 2009 to determine the duration of diarrhea and rate of complications and mortality among toxin-positive (toxin+) and toxin- patients. Overall, toxin- patients had less severe diarrhea, fewer diarrhea days, and lower mortality (P < 0.001, all comparisons) than toxin+ patients. One toxin- patient (n = 1/6121; 0.02%) was diagnosed with pseudomembranous colitis, but there were no complications such as megacolon or colectomy for fulminant CDI among toxin- patients. These data suggest that C. difficile-attributable complications are rare among patients testing negative for C. difficile toxins. More studies are needed to evaluate the clinical significance of C. difficile detection in toxin- patients.

AB - Clostridium difficile testing is shifting from toxin detection to C. difficile detection. Yet, up to 60% of patients with C. difficile by culture test negative for toxins and it is unclear whether they are infected or carriers. We reviewed medical records for 7046 inpatients with a C. difficile toxin test from 2005 to 2009 to determine the duration of diarrhea and rate of complications and mortality among toxin-positive (toxin+) and toxin- patients. Overall, toxin- patients had less severe diarrhea, fewer diarrhea days, and lower mortality (P < 0.001, all comparisons) than toxin+ patients. One toxin- patient (n = 1/6121; 0.02%) was diagnosed with pseudomembranous colitis, but there were no complications such as megacolon or colectomy for fulminant CDI among toxin- patients. These data suggest that C. difficile-attributable complications are rare among patients testing negative for C. difficile toxins. More studies are needed to evaluate the clinical significance of C. difficile detection in toxin- patients.

KW - Clostridium difficile

KW - Diarrhea

KW - Healthcare-associated infection

KW - Outcomes

KW - Toxin

UR - http://www.scopus.com/inward/record.url?scp=84869080321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869080321&partnerID=8YFLogxK

U2 - 10.1016/j.diagmicrobio.2012.08.019

DO - 10.1016/j.diagmicrobio.2012.08.019

M3 - Article

C2 - 23009731

AN - SCOPUS:84869080321

VL - 74

SP - 369

EP - 373

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

SN - 0732-8893

IS - 4

ER -